Wondering how Paxlovid works? This plain-English guide explains how Nirmatrelvir and Ritonavir stop COVID-19 in your body, how fast it works, and more.
If you've been prescribed Paxlovid 150 Mg /100 Mg Dose Pack and want to understand what it actually does in your body, you're in the right place. This guide explains the mechanism of action in plain English — no medical degree required.
Paxlovid is a two-drug combination. Each component has a different job:
Think of the COVID-19 virus like a factory. Once the virus gets inside your cells, it needs to build special tools (proteins) to make copies of itself. One of those tools is an enzyme called Mpro (also known as 3CLpro) — think of it as the virus's main scissors. This enzyme cuts up a large chain of proteins into smaller, functional pieces the virus needs to replicate.
Nirmatrelvir is like putting a lock on those scissors. It binds directly to the Mpro enzyme and blocks it from working. Without functioning scissors, the virus can't assemble the parts it needs. The result? The virus can't make copies of itself, and your immune system gets a chance to catch up and clear the infection.
This makes Nirmatrelvir a protease inhibitor — it inhibits (blocks) the protease (protein-cutting enzyme) that the virus depends on.
Here's where it gets interesting. Nirmatrelvir on its own would be broken down too quickly by your liver. Your body has an enzyme called CYP3A that processes and eliminates many drugs — including Nirmatrelvir. If Nirmatrelvir gets broken down too fast, there isn't enough of it in your blood to fight the virus effectively.
That's where Ritonavir comes in. Ritonavir blocks the CYP3A enzyme in your liver, essentially telling your body: "Don't break down Nirmatrelvir yet — let it keep working." This keeps Nirmatrelvir levels high enough in your blood to do its job.
Ritonavir doesn't directly fight COVID-19. Its role is purely as a pharmacokinetic booster — it protects Nirmatrelvir so it can stay active longer. Think of Ritonavir as a bodyguard for the real fighter.
This is also why Paxlovid has so many drug interactions. Ritonavir blocks the same liver enzyme (CYP3A) that processes dozens of other medications. When those medications can't be broken down normally, their levels can rise to dangerous levels in your blood.
Paxlovid starts working quickly. Nirmatrelvir reaches peak levels in your blood within about 3 to 4 hours of taking a dose. However, you won't necessarily "feel" it working right away because it's fighting the virus at a cellular level.
Most patients begin to notice improvement in their COVID-19 symptoms within the first 2 to 3 days of starting treatment. Clinical trials showed that Paxlovid significantly reduced the risk of hospitalization and death when started within 5 days of symptom onset.
It's important to complete the full 5-day course even if you start feeling better. Stopping early could allow the virus to rebound.
Some patients have reported a return of COVID-19 symptoms or a positive test result after completing their Paxlovid course — a phenomenon known as "Paxlovid rebound." This can happen within 2 to 8 days after finishing treatment. While frustrating, rebound cases are generally mild and resolve without additional treatment. Scientists believe this may be related to the short treatment course rather than a failure of the medication itself.
Nirmatrelvir has a half-life of about 6 to 7 hours when taken with Ritonavir. This means half of the drug is cleared from your body roughly every 6 to 7 hours. After your last dose, Nirmatrelvir is largely cleared within 1 to 2 days.
Ritonavir has a slightly longer half-life of about 3 to 5 hours. Its effects on liver enzymes may linger for a few days after your last dose, which is why your doctor may advise waiting before restarting certain medications that were paused during treatment.
There are a few other COVID-19 treatments available. Here's how Paxlovid compares:
Lagevrio is another oral COVID-19 antiviral, made by Merck. While both are taken at home for 5 days, they work differently:
Learn more in our guide to alternatives to Paxlovid.
Remdesivir is an IV antiviral by Gilead that's FDA-approved for COVID-19 treatment. Key differences:
The 150 Mg /100 Mg Dose Pack provides a reduced dose of Nirmatrelvir specifically for patients with moderate kidney impairment (eGFR 30 to less than 60 mL/min). Because the kidneys play a role in clearing Nirmatrelvir from the body, patients with reduced kidney function need a lower dose to avoid the drug building up to potentially unsafe levels. The Ritonavir dose stays the same at 100 mg.
If you're unsure which dose pack is right for you, talk to your doctor. They'll check your kidney function and prescribe the appropriate version. For more details on dosing and usage, see our guide on what Paxlovid is and how to take it.
Paxlovid 150 Mg /100 Mg Dose Pack works through an elegant two-part strategy: Nirmatrelvir blocks the virus's ability to replicate, and Ritonavir keeps Nirmatrelvir active long enough to do its job. It's one of the most effective oral treatments available for COVID-19 in high-risk patients.
If you've been prescribed Paxlovid and need help finding it, visit Medfinder to check pharmacy availability near you.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
